MicroRNA-23a mediates mitochondrial compromise in estrogen deficiency-induced concentric remodeling via targeting PGC-1α

Journal of Molecular and Cellular Cardiology

Volumn 75, Issue , 2014, Pages 1-11

  Sun, Lu Yao ^a   Wang, Ning ^a   Ban, Tao ^a   Sun, Ying Hui ^a   Han, Yue ^a   Sun, Lin Lin ^a   Yan, Yan ^a   Kang, Xiao Hui ^a   Chen, Si ^a   Sun, Li Hua ^a   Zhang, Rong ^a   Zhao, Ya Jun ^a   Zhang, Hao ^a   Ai, Jing ^a   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Concentric remodeling; E2 deficiency; MiR 23a; Mitochondrial; PGC 1

Indexed keywords

MICRORNA; MICRORNA 23A; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG; ESTROGEN; MIRN23B MICRORNA, MOUSE; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL STRUCTURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ECHOCARDIOGRAPHY; ESTROGEN DEFICIENCY; FEMALE; HEART MUSCLE; HEART VENTRICLE REMODELING; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OVARIECTOMY; OXIDATIVE PHOSPHORYLATION; POSTMENOPAUSE; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; C57BL MOUSE; CELL RESPIRATION; DEFICIENCY; GENETICS; HEART MITOCHONDRION; HEART MUSCLE CELL; METABOLISM; MOLECULAR GENETICS; NEWBORN; NUCLEOTIDE SEQUENCE; PATHOLOGY; ULTRASTRUCTURE;

MUS;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CELL RESPIRATION; DOWN-REGULATION; ESTROGENS; FEMALE; MICE, INBRED C57BL; MICRORNAS; MITOCHONDRIA, HEART; MOLECULAR SEQUENCE DATA; MYOCARDIUM; MYOCYTES, CARDIAC; POSTMENOPAUSE; TRANSCRIPTION FACTORS; VENTRICULAR REMODELING;

EID: 84907538610     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.012     Document Type: Article

References (62)

1. Barrett-Connor E. Menopause, atherosclerosis, and coronary artery disease. Curr Opin Pharmacol 2013, 13:186-191.
2. Cheng S., Fernandes V.R., Bluemke D.A., McClelland R.L., Kronmal R.A., Lima J.A. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 2009, 2:191-198.
3. Pierdomenico S.D., Di Nicola M., Pierdomenico A.M., Lapenna D., Cuccurullo F. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis. J Hum Hypertens 2011, 25:585-591.
4. Berger J., Ren X., Na B., Whooley M.A., Schiller N.B. Relation of concentric remodeling to adverse outcomes in patients with stable coronary artery disease (from the heart and soul study). Am J Cardiol 2011, 107:1579-1584.
5. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Porcellati C. Early cardiac changes after menopause. Hypertension 1998, 32:764-769.
6. Hinderliter A.L., Sherwood A., Blumenthal J.A., Light K.C., Girdler S.S., McFetridge J., et al. Changes in hemodynamics and left ventricular structure after menopause. Am J Cardiol 2002, 89:830-833.
7. Kehat I., Davis J., Tiburcy M., Accornero F., Saba-El-Leil M.K., Maillet M., et al. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res 2011, 108:176-183.
8. Cheng S., Xanthakis V., Sullivan L.M., Lieb W., Massaro J., Aragam J., et al. Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham heart study. Circulation 2010, 122:570-578.
9. Abel E.D., Doenst T. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res 2011, 90:234-242.
10. Elliott H.R., Samuels D.C., Eden J.A., Relton C.L., Chinnery P.F. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008, 83:254-260.
11. Bates M.G., Hollingsworth K.G., Newman J.H., Jakovljevic D.G., Blamire A.M., MacGowan G.A., et al. Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers. Eur Heart J Cardiovasc Imaging 2013, 14:650-658.
12. Chen J.Q., Cammarata P.R., Baines C.P., Yager J.D. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009, 1793:1540-1570.
13. Patten I.S., Arany Z. PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab 2012, 23:90-97.
14. Leone T.C., Lehman J.J., Finck B.N., Schaeffer P.J., Wende A.R., Boudina S., et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 2005, 3:e101.
15. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 2005, 1:259-271.
16. Hsieh Y.C., Yang S., Choudhry M.A., Yu H.P., Bland K.I., Schwacha M.G., et al. Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1. Am J Physiol Heart Circ Physiol 2006, 290:H416-H423.
17. Hsieh Y.C., Choudhry M.A., Yu H.P., Shimizu T., Yang S., Suzuki T., et al. Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J 2006, 20:1109-1117.
18. Hsieh Y.C., Yu H.P., Suzuki T., Choudhry M.A., Schwacha M.G., Bland K.I., et al. Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Cell Cardiol 2006, 41:511-521.
19. Mattingly K.A., Ivanova M.M., Riggs K.A., Wickramasinghe N.S., Barch M.J., Klinge C.M. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 2008, 22:609-622.
20. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
21. Quiat D., Olson E.N. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 2013, 123:11-18.
22. Gan Z., Rumsey J., Hazen B.C., Lai L., Leone T.C., Vega R.B., et al. Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. J Clin Invest 2013, 123:2564-2575.
23. Toloubeydokhti T., Pan Q., Luo X., Bukulmez O., Chegini N. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci 2008, 15:993-1001.
24. Zhai P., Eurell T.E., Cotthaus R., Jeffery E.H., Bahr J.M., Gross D.R. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 2000, 279:H2766-H2775.
25. Saito T., Ciobotaru A., Bopassa J.C., Toro L., Stefani E., Eghbali M. Estrogen contributes to gender differences in mouse ventricular repolarization. Circ Res 2009, 105:343-352.
26. Belke D.D., Betuing S., Tuttle M.J., Graveleau C., Young M.E., Pham M., et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002, 109:629-639.
27. Yasumoto K., Takata M., Ueno H., Tomita S., Tomoda F., Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens 1999, 12:921-924.
28. Kadokami T., Frye C., Lemster B., Wagner C.L., Feldman A.M., McTiernan C.F. Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model. Circulation 2001, 104:1094-1097.
29. Lee H.Y., Choi C.S., Birkenfeld A.L., Alves T.C., Jornayvaz F.R., Jurczak M.J., et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab 2010, 12:668-674.
30. Sahin E., Colla S., Liesa M., Moslehi J., Muller F.L., Guo M., et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-365.
31. Kobayashi T., Watanabe Y., Saito Y., Fujioka D., Nakamura T., Obata J.E., et al. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury. Cardiovasc Res 2010, 85:785-795.
32. Ferguson M., Mockett R.J., Shen Y., Orr W.C., Sohal R.S. Age-associated decline in mitochondrial respiration and electron transport in Drosophila melanogaster. Biochem J 2005, 390:501-511.
33. Sumitomo-Ueda Y., Aihara K., Ise T., Yoshida S., Ikeda Y., Uemoto R., et al. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice. Hypertension 2010, 56:430-436.
34. Foppa M., Duncan B.B., Rohde L.E. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?. Cardiovasc Ultrasound 2005, 3:17.
35. Karamanlidis G., Bautista-Hernandez V., Fynn-Thompson F., Del Nido P., Tian R. Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail 2011, 4:707-713.
36. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochem J 2011, 435:297-312.
37. Lehman J.J., Boudina S., Banke N.H., Sambandam N., Han X., Young D.M., et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol 2008, 295:H185-H196.
38. Ganau A., Saba P.S., Roman M.J., de Simone G., Realdi G., Devereux R.B. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995, 13:1818-1822.
39. Dai D.F., Santana L.F., Vermulst M., Tomazela D.M., Emond M.J., MacCoss M.J., et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009, 119:2789-2797.
40. Marin-Garcia J., Pi Y., Goldenthal M.J. Mitochondrial-nuclear cross-talk in the aging and failing heart. Cardiovasc Drugs Ther 2006, 20:477-491.
41. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
42. Florian M., Freiman A., Magder S. Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 2004, 69:779-787.
43. Siow R.C., Li F.Y., Rowlands D.J., de Winter P., Mann G.E. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med 2007, 42:909-925.
44. Itkonen P., Collan Y. Mitochondrial flocculent densities in ischemia. Digestion experiments. Acta Pathol Microbiol Immunol Scand A 1983, 91:463-468.
45. Kloner R.A., Ganote C.E., Whalen D.A., Jennings R.B. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am J Pathol 1974, 74:399-422.
46. Schaper J., Hehrlein F., Schlepper M., Thiedemann K.U. Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery. J Mol Cell Cardiol 1977, 9:175-189.
47. Kemper M.F., Zhao Y., Duckles S.P., Krause D.N. Endogenous ovarian hormones affect mitochondrial efficiency in cerebral endothelium via distinct regulation of PGC-1 isoforms. J Cereb Blood Flow Metab 2013, 33:122-128.
48. Macari C., Teyssier C., Tribollet V., Mouzat K., Forcet C., Horard B., et al. Estrogens repress PGC1-alpha expression in the uterus. Mol Cell Endocrinol 2010, 330:33-40.
49. Wang B., Hsu S.H., Frankel W., Ghoshal K., Jacob S.T. Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha. Hepatology 2012, 56:186-197.
50. Siegel C., Li J., Liu F., Benashski S.E., McCullough L.D. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci U S A 2011, 108:11662-11667.
51. Weisz A., Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 1988, 2:816-824.
52. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
53. Li X., Liu X., Xu W., Zhou P., Gao P., Jiang S., et al. c-MYC regulated miR-23a~24-2~27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem 2013, 288:18121-18133.
54. Unger R.H. Lipotoxic diseases. Annu Rev Med 2002, 53:319-336.
55. Haemmerle G., Moustafa T., Woelkart G., Buttner S., Schmidt A., van de Weijer T., et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat Med 2011, 17:1076-1085.
56. Lopaschuk G.D., Ussher J.R., Folmes C.D., Jaswal J.S., Stanley W.C. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010, 90:207-258.
57. Sugden M.C., Holness M.J. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem 2006, 112:139-149.
58. Christe M.E., Rodgers R.L. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 1994, 26:1371-1375.
59. Rosano G.M., Vitale C., Fini M. Cardiovascular aspects of menopausal hormone replacement therapy. Climacteric 2009, 12(Suppl. 1):41-46.
60. Hodis H.N. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart. Cleve Clin J Med 2008, 75(Suppl. 4):S3-S12.
61. Haines C.J., Farrell E. Menopause management: a cardiovascular risk-based approach. Climacteric 2010, 13:328-339.
62. Harman S.M. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend Med 2006, 3:254-269.